FindTrial
Sign In

To compare the role of dexamethasone when given via different routes in preventing sore throat in patients after general anaesthesia.

To compare the efficacy of equal dose of dexamethasone in preventing post anaesthesia sore throat when given via three different routes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/08/009524
Enrollment
90
Registered
2017-08-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients posted for surgery under general anaesthesia

Interventions

Intervention1: Intravenous dexamethasone.: Intravenous dexamethasone 8mg or normal saline (total volume 4ml)will be given intravenous over 1 minute according to randomization before induction to all

Sponsors

Shalini Sharma
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1,2 & 3 patients. Age above 18. Duration of surgery less than two hours

Exclusion criteria

Exclusion criteria: Patients who are allergic to dexamethasone. Anticipated difficult intubation. Patients who need nasogastric tube. Patients on steroids. Surgeries requiring manipulation of airway. Patients with sore throat or hoarseness of voice

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of equal dose of dexamethasone in preventing post anaesthesia sore throat and hoarseness when given via three different routes ie intravenous, nebulisation and after dipping the cuff before intubation.Timepoint: 24 hourly till discharge.—

Secondary

MeasureTime frame
Post operative nausea and vomiting.Timepoint: Every 2 hourly in the post operative period till 24 hours.;Requirement of analgesics in post operative period.Timepoint: Every 2 hourly till 24 hours.—

Countries

India

Contacts

Public ContactShalini Sharma

Dr Rajendra Prasad Govt. Medical College Tanda at Kangra

shalini.medico@gmail.com9418011121

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 15, 2026